The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Are You Informed About Informed Consent?

Are You Informed About Informed Consent?

May 1, 2008 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

This is Part One of a two-part series focusing on the clinician’s role in clinical trials. Part Two will explore the ethics of recruiting patients for Phase 1 trials.

You Might Also Like
  • Online Tool Helps RA Patients Make Informed Decisions
  • Safety First
  • Ethics Forum: The Ethical Challenges of Recruiting Patients for Clinical Trials
Explore This Issue
May 2008
Also By This Author
  • New Kits Address Pediatric-to-Adult-Care Transition

In July of 2007, trials for a gene-based intervention for arthritis were temporarily suspended following the death of Jolee Mohr, a participant. Although investigations by both the Food and Drug Administration and the company resulted in findings that the investigational treatment was not at fault and the trial has been restarted, some questions were raised about the nature of the informed consent and the role the patient’s community-based physician played in her recruitment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At one time, clinical trials in the United States were almost entirely within the purview of the academic medical center (AMC). In 1991, 80% of industry money for clinical trials went to AMCs.1 By 2007, the community physician was getting nearly 77% of the spending for clinical investigations.2

In both instances, in the United States, the Institutional Review Board (IRB) takes the lead in approving the outlines of a protocol and making sure these meet the various legal, ethical, and regulatory requirements.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The IRB serves as an arm of the Office for Human Research Protection [OHRP], of [the Department of Health and Human Services] and is charged with local oversight in institutions involved in human subject research,” says Elan Czeisler, director of the IRB for New York University Medical Center in New York City. “They are charged with both the review and oversight of research and ensure that they comport with safeguards enacted by legislation and regulations in place to protect research subjects.”

One major concern for physicians thinking about participating in a clinical trial is in the area of informed consent.

“According to federal statute, informed consent has to be an educational process and not just a form people sign,” says Eric Matteson, MD, chair of the division of rheumatology at the Mayo Clinic in Rochester, Minn. “Research subjects have to voluntarily decide to participate in research and it is important that they clearly understand everything about the trial, including the very substantial risk that is sometimes involved.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The most meaningless question an investigator can ask is, ‘Do you understand?’ That isn’t really a question, but rather a statement designed to get a yes.

—Eric Matteson, MD

Informed Consent in Clinical Trials Different from Regular Practice

Informed consent in a clinical trial differs greatly from the informed consent obtained before surgery. One of the aspects least understood by both subject and investigator is the focus of the interventions.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Academic, Clinical research, clinical trial, community, FDA, Informed Consent, Research, rheumatologyIssue: May 2008

You Might Also Like:
  • Online Tool Helps RA Patients Make Informed Decisions
  • Safety First
  • Ethics Forum: The Ethical Challenges of Recruiting Patients for Clinical Trials
  • Registered Nurses Can Help Guide Rheumatology Patients Through Clinical Trials

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.